Therapeutic, dietary or cosmetic use of compounds with specific anti-apoptotic activity toward caspase-3, and compositions containing these compounds
AssigneeGiuliani S.P.A.
InventorsGiammaria Giuliani, Anna Benedusi, Sergio Baroni
Life of this patent
Estimating the term…
Abstract
This invention regards the use of zeaxanthin and/or rutin, as such or further combined with spermidine, as the active principle in a pharmaceutical, dietary, or cosmetic composition, acting to inhibit caspase-3 and therefore to control apoptosis by preventing programmed cell death. The indication for this composition according to the invention is primarily the treatment of scalp disorders characterized by excessive cellular turnover including chemotherapy-induced alopecia, alopecia areata, androgenetic alopecia and telogen effluvium.
Claims20
A method for treating scalp disorders in humans by administering zeaxanthin, as such or combined with either rutin or spermidine, or both rutin and spermidine.
A pharmaceutical, dietary, or cosmetic composition to treat scalp disorders including chemotherapy-induced alopecia, alopecia areata, androgenic alopecia and telogen effluvium, characterized by comprising as the active principle zeaxanthin, as such or combined with either rutin or spermidine, or both rutin and spermidine.
(canceled)
(canceled)
Dependencies are inferred from the claim text.